REFERENCES
- Altman DG. Diagnostic tests. In: Practical statistics for medical research. London: Chaman and Hall, 1995: 409–411.
- Bishoff JT, Reyes A, Thompson IM, et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 1995; 45: 270–274.
- Danella IF, DeKemion JB, Smith RB, Steckel J. The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol 1993; 149: 1488–1491.
- De Antoni Crawford ED. Prostate cancer awareness week, education, service and research in a community setting. Cancer 1995; 75: 1874–1875.
- Flanigan RC, Mohler JL, King CT, et al. Preoperative lymph node evaluation in prostatic cancer patients who are surgical candidates: the role of lymphangiography and computerized tomography scanning with direct fine needle aspiration. J Urol 1985; 134: 84–87.
- Gervasi LA, Mata JE, Easley JD, et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989; 142: 332–336.
- Goethlin JH. Post-lymphangiographic percutaneous fine needle biopsy of lymph nodes guided by fluoroscopy. Radiology 1976; 120: 205–207.
- Goethlin JH, Hoeiem L. Percutaneous fine-needle biopsy of radiographically normal lymph nodes in the staging of prostatic carcinoma. Radiology 1981; 141: 351–354.
- Goethlin J, Fuchs W A standardized scheme for the lymphographic diagnosis of malignant, metastatic spread. 3rd International Congress Eur Ass Radiol, 1973, Madrid.
- Hermanek P. Sobin LH TNM classification of malignant tumours. 4th ed., 2nd rev., Berlin: Springer-Verlag, 1992: 141–144.
- Kidd R, Crane RD, Dail DH. Lymphangiography and fine-needle aspiration biopsy: ineffective for staging early prostate cancer. AIR 1984; 141: 1007–1012.
- Kleer E, Larson-Keller Zincke H, Oesterling JE. Ability of preoperative serum prostate antigen value to predict pathologic stage and DNA ploidy: influence of clinical stage and tumour grade. Urology 1993; 41: 207–216.
- Partin A, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathologic stage in men with prostate cancer. J Urol 1993; 150: 110–114.
- Paulson DF. The prognostic role of lymphadenectomy in adenocarcinoma of the prostate cancer. Urol Clin North Am 1980; 7: 615–622.
- Petros JA, Catalona WJ. Lower incidence of unsus-pected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 1992; 147: 1574–1575.
- Prout GR, Heaney JA, Griffin PP, Daly JJ, Shipley WU. Nodal involvement as prognostic indicator in patients with prostatic carcinoma. J Urol 1980; 124: 226–231.
- Oyen RH, Van Poppel HP, Ameye FE, et al. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospec-tive study of 285 patients. Radiology 1994; 190: 315–322.
- Mostofi FK, Sesterhenn IA, Sobin LH. Histologic typing of prostate tumours. In: International Histological Classification of Tumours, No. 22. World Health Organization, Geneva, 1980.
- Rogers E, Gurpinar T, Dillioglugil MW, et al. The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer. Br J Urol 1996; 78: 419–425.
- Stuart Wollf Jr J, Cher M, Dall'era M, et al. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of lymph node metastases before radical prostatectomy. J Urol 1995; 7: 993–999.